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The time of spread of human immunodeficiency virus type 1 (HIV-1) from lymphoid to nonlymphoid tissues
in the course of infection was investigated by sequence comparisons of variants infecting a range of lymphoid
and nonlymphoid tissues from three individuals with AIDS in the p17gag gene and regions flanking the V1/V2
hypervariable regions. Phylogenetic analysis in both regions revealed several lineages in each individual that
contained sequences from both lymphoid and nonlymphoid tissues such as the brain. This observation
contrasts strongly with the previously described organ-specific sequences in the V3 region in this study
population and other investigations. Although individual pairwise comparisons of relatively short sequences
such as p17gag are subject to considerable stochastic error, we found that the diversity of gag sequences in
variants from lymphoid tissue was consistently lower than that found among variants amplified from the brain.
By estimating mean synonymous pairwise distances in the p17gag region, we were able to make an approximate
calculation of the ages of populations in different tissues. Those from lymphoid tissue ranged from 2.65 to 5.6
years in the three study subjects, compared with 4.1 to 6.2 years for variants in the brain. Indeed, variants
infecting the brain were no more closely related to each other than they were to variants infecting other tissues
in the body. In two of the three individuals, these times of divergence indicate that infection of the brain may
have occurred as an early event in the progression to disease, preceding the onset of AIDS by several years. This
study is the first in which it was possible to estimate times of diversification in different tissues in vivo and is
of importance in understanding the dynamics of the spread of HIV-1 into nonlymphoid tissues and its possible
adaptation for replication in different cell types.
Infection with human immunodeficiency virus (HIV) is as-
sociated with a slow, progressive, and irreversible impairment
of the immune system, eventually leading to AIDS. Inherent in
the nature of infection with HIV type 1 (HIV-1) is the pro-
longed asymptomatic period that precedes the development of
disease (2, 11, 28, 35), where infection may be subclinical for as
long as 10 to 15 years. This phenomenon was originally hy-
pothesized to result from viral latency, whereby viral or provi-
ral DNA became integrated into the host genome with the
simultaneous cessation of viral expression and independent
replication (2). The ensuing progression to AIDS would then
result from subsequent reactivation of virus replication by var-
ious factors acting upon infected cells, such as antigens, mito-
gens, and transcriptional factors produced by other viruses.
However, it has been recently shown that from the time of
seroconversion, there is active replication of the virus in lym-
phoid tissues (11, 28, 35). There are few convincing demon-
strations of active infection of nonlymphoid tissues until later
in infection, and this change in distribution may be associated
with increased immunosuppression in AIDS (9). Alternatively,
it is possible that variants detected in nonlymphoid tissues such
as the brain in patients with AIDS have been continuously
present from initial infection but that infection becomes clin-
ically significant only during severe immunosuppression. In this
model, HIV encephalitis could be regarded as reactivation
rather than de novo infection.
This study was undertaken to estimate the time of spread of
HIV-1 to nonlymphoid tissues to determine whether reactiva-
tion or actual virus spread was responsible for the pathology
observed in nonlymphoid tissues in AIDS. In order to do this,
we obtained sequences from the p17gag region and V1/V2
flanking regions of HIV-1. The p17gag region was chosen be-
cause most nucleotide differences in this region are synony-
mous and therefore are not subject to positive selection pres-
sures for sequence change, such as those that may be
encountered by immunological recognition by antibody or cy-
totoxic T cells (36). Variations at silent sites occur at frequen-
cies similar to those in the rest of the genome, and it has
already been demonstrated in previous epidemiological studies
that sequence relationships in this region reflect the evolution-
ary history of the virus (15, 17, 20). The rate of sequence
change of this region (p17gag) has previously been determined
from hemophiliacs infected from a common source (20), al-
lowing the time of divergence between any pairs of sequences
to be determined. This region is therefore of use in recon-
structing epidemiological relationships between HIV-1-in-
fected individuals (17) and can be extended to the comparison
of variants within different cell types within a single infected
individual.
Tissues from various lymphoid and nonlymphoid organs
were obtained at autopsy from a number of HIV-1-positive
patients known to have a high viral load in the brain and
evidence of giant cell encephalitis by pathology. Phylogenetic
analyses of both p17gag and V1/V2 flanking regions were car-
ried out in order to explore the relationships among the vari-
ous lineages present and the spread of infection to nonlym-
phoid tissues. It was possible to estimate the time of divergence
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between lymphoid and nonlymphoid tissues, allowing us to
determine the length of time prior to death at which nonlym-
phoid tissues become infected.
MATERIALS AND METHODS
Patient samples. Tissues from various organs were obtained at autopsy, car-
ried out within 3 days of death, from three individuals who died with AIDS-
defining illnesses. All individuals showed evidence of HIV infection of the brain
upon postmortem examination, as determined by the histological appearance of
giant cells, the detection of p24 by immunocytochemistry, and the finding of high
proviral loads in the brain by quantitative PCR (9). Pathological examination of
the fixed brains revealed evidence of atrophy on external examination, and this
was confirmed on section by the presence of ventricular dilatation and opening
up of the sulci in all three patients. In one case (P6), a focal 1-cm-diameter lesion
was identified on macroscopic inspection in the right basal ganglia. Histological
examination of this lesion showed that it was a primary central nervous system
lymphoma. Neither of the other two patients showed macroscopic focal lesions
of the brain. Histological examination in all three patients displayed evidence of
quite florid HIV encephalitis and leukoencephalopathy, characterized by giant
cells and focal collections of macrophages and microglial cells, associated with
myelin damage. There was no evidence of perivascular or leptomeningeal in-
flammatory infiltrates, and, in particular, lymphocytes were not identified within
the central nervous system parenchyma. Further results of the pathological
examinations of these three individuals and quantitation of HIV DNA sequences
in brain and other tissues have been reported previously (8, 9). Clinical infor-
mation in addition to the previous description (9) for the 4 or 5 years prior to
death is summarized in Fig. 1. Samples of brain (left frontal lobe), spinal cord,
lymph node (mesenteric), lung, and colon tissues from these patients were
dissected into 1- to 2-cm pieces and stored at 2708C.
Preparation of DNA. Extraction of DNA from these tissues was carried out by
resuspending small pieces of tissue in 500 ml of lysis buffer (50 mM Tris hydro-
chloride [pH 8.0], 100 mM NaCl, 50 mM EDTA, 1% sodium-n-lauroylsarcosine,
100 mg of proteinase K per ml). The digestion process was allowed to continue
for 2 h at 658C. This was followed by phenol-chloroform extraction and ethanol
precipitation. DNA pellets were dried and resuspended in 100 to 200 ml of
distilled water. The concentration of DNA in each sample was determined by
UV absorbance at wavelengths of 260 and 280 nm.
Detection of provirus. Proviral DNA was amplified and quantified by a pre-
viously described limiting dilution and nested PCR method (43). Amplification
of DNA was carried out with primers flanking hypervariable regions 1 and 2 from
env and p17 from gag. The nucleotide sequences of the primers were as follows:
for V1/V2, a, GAG GAT ATA ATC AGT TTA TGG, 1 (sense), 6539; b, GA
TCA AAG CCT AAA GCC ATG, 1, 6560; c, TTG AAA GAG CAG TTT, 2
(antisense), 6677; d, T(G/A)A AAA ACT GCT CTT TCA A, 1, 6684; e, CAA
TAA TGT ATG GGA ATT GG, 2, 6857; and f, AAT GTA CTG TGC TGA
CAT T,2, 6944; for gag, g, GCG AGA GCG TCA GTA TTA AGC GG,1, 795;
h, GGG AAA TTC GGT TAA GGC C, 1, 835; i, CTT CTA TTT TTA CCC
ATG C,2, 1248; and j, TCT GAT AAT GCT GAA AAC ATG GG,2, 1296 (all
positions numbered according to the HXB2 genome [33]). Amplification of
target DNA was accomplished by using a thermal cycle of 36 s at 948C, 42 s at
508C for gag or 468C for V1/V2, and 40 s at 728C for strand extension. Each
template strand was subjected to 25 cycles of amplification.
Sequence analysis. Single molecules of HIV provirus were isolated by limiting
dilution and amplified in a nested PCR to produce sufficient DNA to allow direct
sequencing of the PCR products. Direct sequencing of amplified DNA was
achieved by using a solid-phase sequencing method. The second PCR was per-
formed in a 100-ml volume with one biotin-labelled primer and one unlabelled
primer (5 to 10 pmol per reaction mixture), generating a PCR product with one
strand having a biotin moiety at either the 59 or 39 end. PCR products were
immobilized on streptavidin-coated magnetic beads (Dynal), and single strands
of DNA were purified by magnetic separation and sequenced according to the
manufacturer’s (Sequenase version 2.0) protocol. After this sequencing reaction,
5 to 6 ml of the reaction product was then electrophoresed on a denaturing
polyacrylamide gel (6% acrylamide, 0.3% N9,N-bisacrylamide, 8 M urea, 0.089 M
Tris, 0.089 M boric acid, 0.002 M EDTA, pH 8.3). Gels were fixed, dried, and
exposed overnight on X-Omat film.
Phylogenetic analysis. Sequence comparisons between viruses from the three
study patients were made for the p17gag gene and hypervariable flanking regions
of V1 and V2 of the env gene of HIV-1. The amplified p17gag region began at
nucleotide 795 of HXB2 and extended to position 1319. The amplified V1/V2
region began at position 6539 of HXB2 and extended to position 6976. The
length of the gag region used for sequence comparisons was 413 nucleotides, and
that of the V1/V2 region was 297 nucleotides. An unrooted phylogenetic tree for
all 85 p17gag nucleotide sequences and 99 V1/V2 nucleotide sequences obtained
from lymph node, brain, and lung samples was constructed by the neighbor-
joining method using the NEIGHBOR program in the PHYLIP package (ver-
sion 3.5) (12). Distances between each pair of sequences were estimated by using
the DNADIST program in the PHYLIP package (version 3.5) (12). Rooted trees
were constructed for each patient by bootstrap resampling (500 replications)
using the MEGA package with the sequence of HIVMN as an outgroup (25).
Phylogenetic analysis of the env region was confined to regions flanking the V1
and V2 hypervariable regions because of the indeterminate and often arbitrary
alignment of the hypervariable sequences.
Nucleotide sequence accession numbers. The sequences obtained in this study
have been submitted to GenBank and assigned accession numbers U79785 to
U79869 (gag) and U79870 to U79957 (U1/U2).
RESULTS
Rate of sequence change in p17gag regions. An unrooted
neighbor-joining tree was constructed by using 85 sequences
from the p17gag region (positions 835 to 1270 in the HXB2
clone [33]) from a range of lymphoid and nonlymphoid tissues
of three HIV-infected individuals dying from AIDS. The se-
quences from each of the three study patients were distinct,
grouping separately into three clades. Bootstrap resampling
supported the distinction of three separate groups (Fig. 2).
All three study subjects were infected with HIV through
drug abuse in 1982 or 1983. Previous phylogenetic studies have
implicated a common source of infection for the majority of
drug users in Edinburgh, United Kingdom, including the three
described here (15). The current sequence differences between
FIG. 1. Clinical and laboratory markers of disease progression in the three study patients in the 5 years before death. The duration of infection in each individual
was estimated to be 9 or 10 years. Each CD4 count shown is the mean count for the indicated year. Abbreviations: AZT, zidovudine; PCP, Pneumocystis carinii
pneumonia; OHL, oral hairy leukoplakia.
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the study subjects therefore must have originated from a pro-
cess of divergent sequence change over a period of between 9
and 10 years. By using a mean figure of 9.5 years (or 19 years
of divergent sequence change), the mean synonymous pairwise
distances in the gag region between individual (0.149) indicated
a rate of sequence change of 0.0077 per site per year. The rate
of sequence change between pairs of individuals was similar,
ranging from 0.006 to 0.009 (Table 1; Fig. 3A through C). This
estimate was similar to those obtained in previous studies. For
example, sequence comparisons in the p17gag region of plasma
RNA sequences from hemophiliacs infected from a common
source indicated a mean rate of synonymous substitution in
p17gag of 0.006 to 0.0072 substitutions/site/year (21).
The mean rate of nonsynonymous substitution between the
study subjects was 0.0058, lower than the silent rate. The mean
dN/dS ratio of 0.41 indicated a bias toward silent substitutions
in this region of the gag gene, consistent with previous esti-
mates (13, 20, 26, 34).
In this study, we also determined the sequences of the V1
and V2 hypervariable regions and flanking regions in the env
region from the three study patients (positions 6560 to 6876).
Between individuals, the mean pairwise synonymous distance
between sequences from the flanking regions (but omitting the
hypervariable regions between positions 6623 to 6679 [V1] and
6701 to 6796 [V2]) was 0.104, lower than for the p17gag region.
In contrast, the rate of nonsynonymous substitution in the
V1/V2 flanking region was higher (0.083), producing an overall
dN/dS ratio of 0.80, similar to previous estimates for the env
region (26, 48).
In this study, we used the measured rate of sequence change
in the p17gag region at silent sites to estimate the time of
divergence between variants infecting different tissues within
an infected individual. These data should indicate when the
spread of HIV into nonlymphoid tissues occurred (9).
Phylogenetic analysis of variants from different tissues. Phy-
logenetic analyses using sequences from the p17gag region and
V1 and V2 flanking regions from a range of lymphoid and
nonlymphoid tissues were carried out to determine the relat-
edness of variants between each tissue (e.g., lymph node, brain,
and lung) (Fig. 4). Bootstrap resampling using 500 replicate
trees was carried out to estimate the robustness of observed
groupings.
In none of the patients was there consistent phylogenetic
grouping by tissue origin. For example, p17gag sequences from
lymph node samples of patient P4 were found in two distinct
lineages, both of which contained a variety of sequences from
other tissues (lung and spleen) (Fig. 4A). Similarly, sequences
from brain samples were interspersed with those from colon,
lung, and spinal cord samples. In the V1/V2 flanking regions,
there was an even more marked splitting of sequences into
different lineages separated by high bootstrap values (Fig. 4D).
For example, sequences from the brain were found in lineages
a, b, and d, of which the latter two include sequences from
lymphoid tissues (lymph nodes and spleen).
Similar mixing of sequences from lymphoid and nonlym-
phoid tissues was observed among sequences from the other
two study subjects (Fig. 4B, C, E, and F). For example, p17gag
sequences from both brain and lymphoid tissue samples of
patient P5 were found on lineages a and b, separated from
each other by high bootstrap values (Fig. 4B). In patient P6,
sequences were obtained only from brain and lymph node
samples but each of the lineages contained sequences from
both sources (Fig. 4C and F).
Times of divergence of HIV variants in different tissues.
Pairwise synonymous distances between sequences from the
p17gag region from each patient were calculated to estimate the
time of divergence of variants within each tissue. The previ-
ously established rate of sequence change in the p17gag region
of 0.0066 substitutions per site per year was used (20), although
similar results would have been obtained if we had used the
synonymous substitution rate observed in this study (mean of
three study individuals, 0.0077).
Mean synonymous pairwise sequence distances within study
subjects were calculated by comparing sequences from all tis-
sues with each other, as well as comparisons restricted to
variants found in particular tissues, such as brain, lymph node,
and lung tissues (Table 2; Fig. 3D through F). Comparisons of
variants found in all tissues produced a range of pairwise dis-
tances from 0.035 to 0.086, approximately a third of the mean
interpatient silent distance. These distances implied times of
divergence of 2.6 to 6.5 years (Table 2).
For all three patients, the mean distance between sequences
from brain tissue was greater than the mean distance between
variants in lymphoid tissue (Table 2; Fig. 5), reflecting their
wide distribution in multiple lineages by phylogenetic analysis
(Fig. 4). For example, the mean synonymous pairwise distances
calculated for brain tissues ranged from 0.054 to 0.086 years
while those for lymphoid tissues ranged from 0.035 to 0.074
years (P , 0.001). These distances translate into approximate
mean divergence times of 4.1 to 6.5 years and 2.65 to 5.6 years
for brain and lymphoid variants, respectively. Overall, se-
quences between variants found in the brain were no more
similar to each other (0.080 for the three study patients [Table
FIG. 2. Neighbor-joining tree of sequences from the p17gag region of the
three study subjects. Bootstrap values indicate the percentages of trees showing
the observed patient-specific groupings.














P4 and P5 19 960 0.152 0.053 0.35 0.008
P4 and P6 18 736 0.112 0.052 0.47 0.006
P5 and P6 19 689 0.184 0.070 0.38 0.009
All 18.7 795 0.149 0.058 0.39 0.0077
a Based upon infection from a common source in 1982 (see Results).
b Silent substitution rate of sequence change (in substitutions per site per year)
between study subjects.
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2]) than they were to those present in lymphoid tissue (mean
silent pairwise distance between brain and lymph node se-
quences, 0.070).
Mean nonsynonymous pairwise distances were also calcu-
lated and were found to be lower than the distances at silent
sites only. Nonsynonymous distances calculated for brain tissue
ranged only from 0.010 to 0.042 years and were higher than
those observed between variants in lymphoid tissue of the
three study individuals (0.012 to 0.020; P , 0.001). Subse-
quently, these values produced dN/dS ratios of between 0.158
and 0.49 for brain tissue only and between 0.16 and 0.46 for
lymphoid tissue only, similar to those observed previously for
interpatient comparisons. These ratios indicate that most of
the substitutions which occurred within an individual in the
p17gag region were silent.
DISCUSSION
Rate of sequence change of HIV in vivo. In this study, we
used published rates as well as estimates based upon the se-
quences recovered from the study patients to estimate the
times of divergence of variants infecting different tissues in
vivo. Measurement of the rate of sequence change was possible
for the study patients because it was known that all three
patients were originally infected with HIV from a common
source in an outbreak around 1982 or 1983, so each was in-
FIG. 3. Frequency histograms of silent pairwise distances in the p17gag region between study subjects P4 and P5 (A), P4 and P6 (B), and P5 and P6 (C) and within
study subjects between sequences obtained from different tissues of P4 (D), P5 (E), and P6 (F). The median values for distributions are shown in Tables 1 and 2.
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fected for approximately 9 or 10 years prior to death. There-
fore, between any two individuals, there were approximately 19
years of divergent sequence change. Synonymous rates of sub-
stitution were calculated for each patient in p17gag (Table 1)
and ranged from 0.006 to 0.009 substitutions per site per year
(mean, 0.0077), while the rate for the V1/V2 flanking regions
was slightly lower (mean, 0.0056 substitutions per site per
year).
One assumption that must be made when calculating times
of divergence from sequence distances is that the rate of se-
quence change remains constant throughout the course of in-
fection, and there is little direct evidence of whether this is
justified. Although higher levels of virus replication clearly
occur later in the course of disease, this does not necessarily
imply that the rate of sequence change should be higher. The
rate of sequence change is proportional to the number of
replication cycles, whose length is determined by the replica-
tive processes within the cell, unless a substantial proportion of
the sampled population originates from virus that has reacti-
vated from latently infected cells, where viral replication may
not have occurred for several years.
Empirically, however, the rate of sequence change at silent
sites in p17gag over the first 2 years of infection in hemophiliacs
(0.0066 per site per year [20]) was similar to that observed in
the study patients (0.0077), in which the period of infection was
9 or 10 years, covering primary infection to death from AIDS.
These figures are in turn within the range of rates of change
estimated for viral isolates from several other studies (13, 26,
48).
Although the rate of nonsilent sequence change in the gag
region was lower than the synonymous rate, times of diver-
gence based on nonsilent sites were similar to times of diver-
gence of variants in different tissues (mean time of divergence
of variants within each subject, 3.1 years, compared with 3.7
years by using the published rate of silent sequence change in
p17gag [20]). This is in spite of the theoretical possibility that
the rate would be affected by phenotypic selection of variants
with changes in the p17gag region.
By using the mean synonymous rate of substitution for
p17gag of 0.0066 substitutions per site per year (20), the average
time of divergence between brain and lymph node variants
within an individual patient were calculated (Table 2) and a
range of 3.5 to 6.5 years was obtained. In lymphoid tissue, the
mean diversity of gag sequences implied an approximate pop-
ulation age of 2.65 to 5.6 years, while those infecting the brain
were significantly more variable, suggesting an even earlier
time of diversification (4.1 to 6.2 years). Despite the large
potential inaccuracies in calculating times of divergence based
upon sequence distances, it is clear that compared with the
total duration of infection within these patients (9 or 10 years),
the observed diversity within brain tissue suggests infection
relatively early in the course of HIV infection and clearly
preceding the onset of AIDS in two of the three study individ-
uals (Fig. 1).
Organ-specific differences of HIV in the V3 region. Popula-
tions of HIV variants infecting different tissues in vivo are
generally distinct in the V3 hypervariable region of env (1, 23,
37) including the three study patients in the current study (8).
For example, for P5, none of the V3 sequences of either the
major population (15 of 17) or minor population (2 of 17)
found in the brain were found among those from lung, periph-
eral blood mononuclear cell, and lymph node samples; these
tissues were dominated by a variant with a substitution at
position 28 (35 of 42). Similarly, for P6, variants in the brain
were uniform and differed from lymph node variants in all but
one case by 1 to 3 amino acids. The diversity of sequences in
the V3 region of P4 made comparison more difficult, but again
the main variants in the brain (14 of 17) were not found in
peripheral blood mononuclear cell or spleen samples (n 5 16)
FIG. 4. Phylogenetic analysis of sequences obtained from different tissues of
the three study subjects (P4 [A and D], P5 [B and E], and P6 [C and F]) in
different subgenomic regions (p17gag region [A through C] and V1/V2 flanking
regions [D through F]). Trees are shown in rooted form, with the unrelated
subtype B sequence of HIVMN as an outgroup. Bootstrap values of .75% for
branches are in bold. Symbols: 1, brain; }, spinal cord; F, lung; n, colon; h,
lymph node; E, spleen.
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or, with a single exception, in lymph node samples (15 sequenc-
es).
On the basis of this apparent tissue-specific distribution of
variants in V3, it has been suggested that these population
differences have adaptive significance and reflect different tro-
pisms for the different infected cell types in different tissues.
The involvement of V3 would be consistent with the previous
observation of its role in determining the ability of HIV to
replicate in different cell types in vitro (29). Within macroph-
agetropic isolates, an acidic amino acid or alanine was predom-
inantly seen at position 25, while a basic or uncharged amino
acid at this position was associated with nonconservative basic
amino acid substitutions at positions 11, 24, and 32, correlating
with T-cell tropism, consistent with the findings of other stud-
ies (5, 18, 19, 31, 41, 42, 47). Extending this work, Power et al.
(37) compared cloned sequences from the brains and spleens
of demented and nondemented patients and found evidence
for specific amino acid substitutions at two positions in the V3
loop (histidine at position 305 and proline at position 329) that
correlated with neurotropism and the clinical expression of
HIV dementia. However, while other studies have also found
populations infecting the brain separate from those infecting
lymphoid tissues, there appear to be no conserved features of
the V3 loop that correlate with neurotropism (7, 10, 21, 23, 27,
39).
Furthermore, there is no evidence for a correlation between
tissue distribution with the predicted phenotype of such V3
sequences in vitro. For example, in our previous study of the
three study patients and others (8), we found that each tissue
was predominantly infected with variants with a predicted non-
syncytium-inducing (NSI)- or macrophagetropic phenotype,
regardless of tissue origin. In these cases, the observed amino
acid differences between brain and lymphoid tissues were rel-
atively few and probably unlikely on their own to alter the
phenotype of the virus (8) (see below).
Other studies support the conclusion that the V3 region is to
some extent involved in tissue tropism but that interaction with
other regions in the HIV-1 genome is required for infectivity
(3, 4, 22, 44). Stamatos and Cheng-Mayer (44) have suggested
that mutations altering the structure of the V3 loop can affect
the conformation of gp120 and that in turn the structure of the
V3 loop is influenced by the conformation of other regions in
gp120. Carrillo and Ratner (3) have suggested that an inter-
action of the V3 loop with a small region of the C4 domain is
required for infectivity of Jurkat T-cell lines, and previous
studies have suggested a similar association (30, 32, 49). There-
fore, although it is universally accepted that restricted variabil-
ity exists in the V3 loop of HIV-1 gp120, there is no universal
interpretation of this observation.
Multiple evolutionary lineages in p17gag and V1/V2 regions.
Given the previously observed organ-specific populations in
the V3 region, we were surprised to find a different relation-
ship between variants when sequences elsewhere in the ge-
nome were compared. In both p17gag and V1/V2 flanking re-
gions, we observed numerous independent lineages containing
sequences from nonlymphoid tissues such as the brain and lung
mixed with those from lymphoid organs. Some of these group-
ings were confirmed by bootstrap resampling analysis (Fig. 4).
Comparison of the actual V1 and V2 sequences showed a
pattern of sequence variability between tissues similar to that
of the flanking regions and without evidence of tissue-specific
groupings; these data are the subject of a further study (17a).
There are at least three possible explanations for differences
in grouping in different regions of the genomes; these include
(i) different rates of sequence change in different tissues, (ii)
convergence, and (iii) recombination and are reviewed below.
The first hypothesis, originally proposed by Korber et al.
(23), is based upon the principle that infection of nonlymphoid
tissue such as the brain occurs early in the course of infection
at a time when the viral population is relatively homogeneous
in the V3 region. Therefore, variants infecting the brain would
be initially similar to variants infecting nonlymphoid tissues.
Subsequently, as disease progresses, variants found in lym-
phoid tissues may undergo more rapid sequence change in V3
and elsewhere in the genome associated with population re-
placements arising from immune escape or antiviral treatment.
For example, variants resistant to neutralization or to antivirals
such as zidovudine would outgrow other variants present
TABLE 2. Sequence comparisons of variants from different tissues in the p17gag region
Patient(s) Tissue type(s) No. ofsequences
Silent sites Nonsilent sites
Mean distance Mean divergence (yr) Pa Mean distance Pa dN/dSratio
All All 75 0.049 3.72 0.019 0.390
Brain 35 0.080 6.06 0.031 0.390
Lymph node 21 0.055 4.20 ,0.001 0.081 ,0.001 0.270
Lung 15 0.049 3.72 ,0.001 0.013 ,0.001 0.270
P4 All 20 0.042 3.18 0.018 0.430
Brain 7 0.054 4.10 0.010 0.185
Lymph node 7 0.035 2.65 0.004 0.016 0.002 0.460
Lung 6 0.070 5.30 0.058 0.013 0.184 0.190
P5 All 30 0.045 3.40 0.020 0.440
Brain 13 0.082 6.20 0.023 0.280
Lymph
Node
6 0.048 3.60 0.069 0.020 0.533 0.420
Lung 11 0.043 3.25 ,0.001 0.015 ,0.001 0.350
P6 All 23 0.061 4.60 0.020 0.330
Brain 15 0.086 6.50 0.042 0.490
Lymph node 8 0.074 5.60 0.113 0.012 ,0.001 0.160
a Significance of difference between pairwise distances among brain variants compared with those in other tissues by nonparametric Kruskall-Wallis test.
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within the lymphoid tissue. Rapid turnover and population
replacements may be facilitated by the continuous movement
of lymphocytes and other susceptible cells through lymphoid
tissue. The previously estimated high rate of turnover of HIV-
infected lymphocytes (14, 46) after antiviral treatment is con-
sistent with the existence of a relatively dynamic lymphoid-cell
population, whereas at least for antiviral resistance, the brain
population is not (44a).
Alternatively, variants infecting lymphoid cells may be sub-
ject to more rapid changes over time associated with changes in
the V3 region that determine the shift in the phenotype of HIV
upon disease progression. Variants in the brain, however, may
be unable to undergo such radical changes in the V3 region
due to the continued strict requirements for replication in cells
of the brain that are largely monocyte-derived cells, i.e., infil-
trating macrophages and microglial cells (38, 45). The survival
of the original infecting population in the brain and its replace-
ment in lymphoid cells would explain the former’s greater
diversity in all parts of the genome other than those that
determine tropism and the observed organ-specific differences
in V3 populations. This hypothesis implies early entry of HIV
into the brain, and although the V3 region is involved in tro-
pism, it is not in the simple way it has been previously imag-
ined.
It is possible to account for the organ-specific populations in
V3 by other processes that do not necessarily imply early entry
into the brain. For example, the organ-specific similarities in
V3 sequences among variants that are not closely related in
evolutionary terms could have originated from a process of
strong convergent evolution, whereby the V3 sequence deter-
mines the ability of variants to grow in different cell types.
Independent evidence for the existence of positive selection
leading to convergence in V3 has been obtained from a study
of hemophiliacs infected from a common source, who showed
similarities in the pattern of sequence change in the V3 region
in different individuals (20). Similarly, a longitudinal study of a
single infected individual showed several independent occur-
rences of certain amino acid changes in the V3 loop in variants
forming two evolutionarily distinct lineages (16).
It is unlikely that the V3 loop could be the sole determinant
of tropism, as the differences between populations infecting
brain and lymphoid tissues are often trivial and would be
unlikely on their own to affect the phenotype of the virus. For
example, all variants in the brain of P5 differed from those of
lymphoid tissue at only one position (position 28), where a
glutamate replaced an aspartate, a conservative amino acid
change. Evidence for the functional equivalence of these two
residues at this position can be inferred from their approxi-
mately equal distribution in isolates of the NSI phenotype and
among variants infecting a range of tissues collected at autopsy
from these and other individuals (7, 10, 21, 23, 27, 37, 39).
Furthermore, if convergence were the explanation for the or-
gan-specific grouping of V3 sequences, we might expect to
observe general similarities between variants infecting specific
tissues from unrelated HIV-infected individuals. However,
apart from one study (37), it has generally proved impossible to
demonstrate any specific conserved sequence or motif in V3 or
elsewhere in env that correlates with the type of cell infected
(see above). On the other hand, as noted above, it is possible
that the actual V3 sequence required for replication in differ-
ent cell types may depend upon interactions between V3 and
other regions of env so that different V3 sequences may evolve
to carry out equivalent functions in different HIV strains.
The other mechanism for different relationships in different
parts of the genome is recombination, where a requirement for
specific V3 sequences that confers an ability to infect different
tissues may favor recombination with an already divergent
preexisting population either within or without the tissue
where the variants are found. Recombination occurs fre-
quently in retroviruses, including HIV-1, and is a mechanism
by which genetic variation can be increased (6). Recombina-
tion requires that multiple infection of cells occurs, and al-
though there is evidence that this may occur in vitro (24, 40),
the scarcity of HIV-infected cells in brain and other tissues
seems to suggest that it may be an unlikely event in vivo.
However, it is possible that recombinants are generated else-
where, where high levels of replication occur (e.g., in lymphoid
tissue), producing variants that are uniquely able to enter and
replicate within the central nervous system.
Whether the similarities in V3 originated from convergence
or recombination, these hypotheses suggest that the observed
FIG. 5. Distribution of pairwise distances in different tissues from the three
study patients at silent (A) and nonsilent (B) sites in the p17gag region.
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diversity of variants within brain tissue could have originated
by a process of multiple entry from sources outside the central
nervous system. Therefore, the actual duration of infection in
the brain may be substantially shorter than can be calculated by
estimating its population diversity. Indeed, the grouping of
variants from brain and lymphoid tissues by phylogenetic anal-
ysis of the p17gag and V1/V2 flanking regions is evidence for a
process of multiple entry. On the other hand, this hypothesis
does not easily explain how populations in the brain should be
consistently more diverse than those in lymphoid tissue or
other presumed sources of infection in the brain (Fig. 5). The
observed greater diversity of p17gag sequences in the brain is
more consistent with the first hypothesis of a lower rate of
population replacement in the brain compared with that in
lymphoid tissue.
In summary, the main findings of this study were the obser-
vation of an unusually diverse population of HIV variants in
the brain without evidence for any closer evolutionary relation-
ship between them than to variants infecting other tissues in
the body. Although late entry of recombinant viruses is a pos-
sibility, it is more likely that viral entry into the brain occurs
relatively early in the course of disease, based upon observa-
tions of its higher diversity in the brain than in other tissues
and the existence of multiple evolutionary lineages containing
sequences from the brain. These findings suggest that the loss
of immune competence is not solely required for entry into
nonlymphoid tissue, and the strong association between HIV-
induced neuropathology and disease progression may be con-
sequent to reactivation rather than de novo infection of the
central nervous system. The finding of variants in the brain on
several different evolutionary lineages challenges the hypoth-
esis of the evolution of a uniquely neurotropic strain. It is
possible that the only requirement for infection of the brain is
macrophage tropism and hence the possession of a V3 loop
sequence that is of low charge and shows few differences from
the subtype B consensus sequence (8).
This study represents the first attempt to use evolutionary
analysis of variants infecting different tissues. The finding of
different interrelationships between variants in different parts
of the genome, combined with uncertainty about the frequency
and site of recombination in vivo and the selection pressures
that could produce convergent evolution in V3, highlights the
complexity in trying to understand the dynamics of HIV rep-
lication and dissemination to different tissues. However, this
research at least provides a starting point for a more rigorous
examination on the existence of HIV tropism in vivo.
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